| 9/3/2010 (Market Closed) | Dow Jones: 10447.93 +127.83 (+1.24%) | Nasdaq: 2233.75 0.00 (0.00%) | S&P 500: 1104.51 0.00 (0.00%) |
|
|
AMAG
(NGM) |
"AMAG Pharmaceutic"
|
25.42
0.00 (0.00%)
(3:59pm) |
|
|
| Bid: | 0.00 |
Ask: | 0.00 |
Day Range: | N/A - N/A |
Volume: | 0 |
|
|
| | |
| |
| |
| |
| Open: | N/A |
Prev Close: | 25.42 |
Market Cap: | 535.1M |
Float Shares: | 21,030,000
|
|
| 3mo Avg Volume: | 329,767 |
52wk Range: | 25.01 - 52.49 |
Chg 52wk Low: | +0.41(+1.64%) |
Chg 52wk High: | -27.07(-51.57%) |
|
| EPS: | -4.502 |
EPS Current Yr: | -4.29 |
EPS Next Yr: | -3.04 |
EPS Next Qtr: | -1.02 |
|
| P/E Ratio: | N/A |
Short Ratio: | 12.90 |
Price/Sales: | 11.08 |
Price/Book: | 1.94 |
|
| Dividend/Share: | 0.00 |
Dividend Yield: | N/A |
Ex-Dividend: | N/A |
Dividend Pay: | N/A |
|
|
| 1yr Target Price: | 41.94 |
Price/EPS Est. Current Year: | N/A |
Price/EPS Est. Next Year: | N/A |
|
| 50day Moving Avg: | 31.0989 |
Chg From 50day Moving Avg: | -5.6789 |
% Chg From 50day Moving Avg: | -18.26%
|
|
| 200day Moving Avg: | 33.8868 |
Chg From 200day Moving Avg: | -8.4668 |
% Chg From 200day Moving Avg: | -24.99% |
|
*Quote & Index 15 min. Delayed |
|
| News & Articles for "AMAG" |
| | | Wed, 11 Aug 2010 17:05:18 GMT
|
Fri, 06 Aug 2010 17:26:35 GMT
|
Thu, 05 Aug 2010 20:39:46 GMT
|
[Business Wire]LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. today announced that management will present an overview of the company at the Canaccord Genuity 30th Annual Global Growth Conference on August 10, 2010 at 9:00 a.m. Tue, 03 Aug 2010 20:05:00 GMT
|
Fri, 30 Jul 2010 19:20:13 GMT
|
| | | AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will present an overview of the company at the Canaccord Genuity 30th Annual Global Growth Conference on August 10, 2010 at 2010 08 03 16:05 Tuesday, August 03, 2010 4:05 PM
|
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel 2010 07 28 16:05 Wednesday, July 28, 2010 4:05 PM
|
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the quarter ended June 30, 2010 after the U.S. financial markets close on July 2010 07 21 16:05 Wednesday, July 21, 2010 4:05 PM
|
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and Takeda Pharmaceutical Company Limited (TSE: 4502) today provided a regulatory and clinical update for FerahemeŽ (ferumoxytol) Injection for intravenous 2010 06 29 06:30 Tuesday, June 29, 2010 6:30 AM
|
| | |
Earnings Postmortem for Abaxis; ABAX, IDXX, AMAG, QDEL
Learning MarketsSep 1, 2010
Abaxis Inc. (ABAX) [ChartAnalysisNews] released its most recent earnings statement about a month ago on Thursday, July 29th. Abaxis Inc. missed expectations with a profit of 16 cents per ...
Wed, 01 Sep 2010 09:38:32 GMT
|
Mon, 30 Aug 2010 06:12:27 GMT
|
Mon, 30 Aug 2010 06:08:29 GMT
|
Options Trader Alert for AMAG Pharmaceuticals (AMAG)
Market IntellisearchAug 27, 2010
NEW YORK (Market Intellisearch) -- Unusual volume of put contracts was traded today. There were 1,591 puts contracts versus the ten day average volume of 240. On the calls side, 98 calls contracts ...
Fri, 27 Aug 2010 22:20:07 GMT
|
Fri, 27 Aug 2010 08:13:36 GMT
|
|
| Symbol |
Volume %
Change |
Price %
Change |
News |
|
| Symbol |
Volume %
Change |
Price %
Change |
News |
|
|
|
